candida fungal infection / thrush

Introduction

Candida sp is a yeast and the main human pathogen in the Candida family has been C. albicans but in 2009, a new species, C. auris was discovered and this organism appears to be developing into a global threat for at risk critically ill hospitalised patients

a very common pathogen which is the cause of oral, vaginal and moist skin fold thrush
- see also wearing underwear - health benefits and adverse effects
may also cause systemic infection in immunocompromised patients and those with long term vascular lines in situ

discovered in 2009
can be resistant to all four major classes of antifungal agents
may cause systemic infection in immunocompromised patients and those with long term vascular lines in situ
mortality rate from systemic infections is 30-50%
was discovered for 1st time in Brazil in 2021
in 2023, there were over 4500 cases in the US and the US FDA approved Rezafungin for invasive Candida infections.
by 2025, it had been documented in hospitals in over 50 countries